Search Results 961-970 of 4544 for 搜索留痕关键词咨询邮箱:lgooxc@hotmail.com
This 8-week randomized, open-label evaluation will examine the acute safety and tolerability of 4 different dosing regimens of Acthar to inform dose selection ...
The primary objective of this study is to determine whether etripamil nasal spray (NS) 70 mg is superior to placebo at terminating episodes of PSVT in an ...
About this study. The goal of the study is to determine if patients undergoing radiofrequency neurotomy of lumbar facet joints that are adjacent to ...
About this study. The purpose of this study is to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor ...
The purpose of this study is to develop an ultrasound method to identify villitis of unknown etiology (VUE)-induced inflammation in the human placenta during ...
The purpose of this study is to utilize amino acid PET such as 18F-DOPA PET/CT for use in brain tumor patients. Participation eligibility. Participant ...
See the application selection process for Benefactor-Funded Research Early-Career Development Awards at Mayo Clinic's Center for Clinical and Translational ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
All patients who complete the 52-week double-blind treatment period on IP may be eligible to continue into an open label extension (OLE) period. The OLE period ...
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.